Afya/$AFYA
1D1W1MYTD1Y5YMAX
Capital at risk
About Afya
Afya Ltd is a medical education group based in Brazil. Its education portfolio has several courses in addition to Medicine, such as Management, Dentistry, Law, Engineering, Nursing, Psychology, and Accounting Sciences, among others. It has three segments; Undergraduate, deriving key revenue provides educational services through undergraduate courses related to medical school, undergraduate health science and other ex-health undergraduate programs, Continuing Education provides medical education, specialization and graduate courses in medicine, delivered through digital and in-person content; and Medical practice solution provides clinical decision, clinical management and doctor-patient relationships for physicians and provide access, demand and efficiency for the healthcare players.
- Ticker
- $AFYA
- Sector
- Consumer Discretionary
- Primary listing
- NASDAQ
- Employees
- 9,395
- Headquarters
- Belo Horizonte, Brazil
- Website
- www.afya.com.br
Afya Metrics
BasicAdvanced
$1.2B
8.01
$1.69
0.38
$0.66
4.84%
Price and volume
Market cap
$1.2B
Beta
0.38
52-week high
$16.43
52-week low
$13.00
Average daily volume
235K
Dividend rate
$0.66
Financial strength
Current ratio
2.201
Quick ratio
2.127
Long term debt to equity
0.595
Total debt to equity
0.633
Dividend payout ratio (TTM)
41.32%
Interest coverage (TTM)
2.74%
Profitability
EBITDA (TTM)
291.6
Gross margin (TTM)
64.02%
Net profit margin (TTM)
20.44%
Operating margin (TTM)
32.66%
Effective tax rate (TTM)
10.61%
Revenue per employee (TTM)
$80,200
Management effectiveness
Return on assets (TTM)
8.41%
Return on equity (TTM)
16.68%
Valuation
Price to earnings (TTM)
8.011
Price to revenue (TTM)
1.626
Price to book
0.25
Price to tangible book (TTM)
-1.74
Price to free cash flow (TTM)
4.943
Free cash flow yield (TTM)
20.23%
Free cash flow per share (TTM)
2.741
Dividend yield (TTM)
4.84%
Forward dividend yield
4.84%
Growth
Revenue change (TTM)
7.91%
Earnings per share change (TTM)
16.75%
3-year revenue growth (CAGR)
13.93%
3-year earnings per share growth (CAGR)
32.36%
What the Analysts think about Afya
Analyst ratings (Buy, Hold, Sell) for Afya stock.
Analyst projections of the future price of Afya stock.
Bulls say / Bears say
Afya’s core undergraduate franchise continues to show solid pricing and volume momentum: first-half Undergraduate revenue rose 7.4%, medical-student enrollment increased 2.7%, the medical-school net average ticket increased 3.9%, and Health Sciences enrollment grew 18.0%. (Nasdaq)
Cash generation supports shareholder returns and financial flexibility: first-half operating cash flow increased 2.9% to R$805.5 million, cash conversion was 87.8%, and Afya returned R$447.9 million through dividends and share repurchases, including buybacks equivalent to approximately 3% of shares outstanding. (Nasdaq)
Management reaffirmed 2026 guidance of R$3.95–4.10 billion in revenue and R$1.70–1.80 billion in adjusted EBITDA, while reporting net debt excluding IFRS 16 of only about 0.8x implied mid-point EBITDA guidance; further medical-seat authorizations also support longer-term capacity growth. (Nasdaq; SEC)
Adjusted EBITDA margin fell 190 basis points year over year to 46.2% in the first half of 2026, while EBITDA growth of 2.8% lagged 7.0% revenue growth as Afya increased investment in Continuing Education and Medical Practice Solutions. (Reuters)
Growth outside the core undergraduate business remains comparatively slow: Continuing Education revenue increased 4.6% in the first half, helped by a mix shift toward lower-ticket short-term programs, while Medical Practice Solutions revenue rose only 1.5%. (Nasdaq)
Regulatory constraints could limit the pace of medical-seat expansion: Brazil cancelled the Mais Médicos III public call, removing a potential source of roughly 5,700 new seats, while recent medical-course performance reviews also included Afya among institutions facing potential restrictions. (SEC; Reuters)
Data summarised monthly by Lightyear AI. Last updated on 9 Sept 2026.
Afya Financial Performance
Revenues and expenses
Afya Earnings Performance
Company profitability
Upcoming events
No upcoming events
Afya News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.